Abstract
Generative deep learning is accelerating de novo drug design, by allowing the generation of molecules with desired properties on demand. Chemical language models – which generate new molecules in the form of strings using deep learning – have been particularly successful in this endeavour. Thanks to advances in natural language processing methods and interdisciplinary collaborations, chemical language models are expected to become increasingly relevant in drug discovery. This minireview provides an overview of the current state-of-the-art of chemical language models for de novo design, and analyses current limitations, challenges, and advantages. Finally, a perspective on future opportunities is provided.
| Original language | English |
|---|---|
| Article number | 102527 |
| Number of pages | 9 |
| Journal | Current Opinion in Structural Biology |
| Volume | 79 |
| DOIs | |
| Publication status | Published - Apr 2023 |
Bibliographical note
Funding Information:The Institute for Complex Molecular Systems (ICMS, TU/e) and the Centre for Living Technologies (Alliance TU/e, WUR, UU, UMC Utrecht) are acknowledged for support. I thank Rıza Özçelik and Michael Moret for valuable discussions on chemical language models.
Funding
The Institute for Complex Molecular Systems (ICMS, TU/e) and the Centre for Living Technologies (Alliance TU/e, WUR, UU, UMC Utrecht) are acknowledged for support. I thank Rıza Özçelik and Michael Moret for valuable discussions on chemical language models.
Fingerprint
Dive into the research topics of 'Chemical language models for de novo drug design: Challenges and opportunities'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver